The increase of Glo-1 activity may represent a strategy adopted by aggressive cancer cells such as triple negative breast cancer cells as a defense mechanism against the glycation damage induced by high intracellular MG accumulation. Here, GLO1 is linked to triple-negative breast carcinoma.